| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.073 | 8.207 | 6.410 | 4.055 | 4.316 | 10.733 | 29.648 | 2.224 | 0 | 0 |
| Total Income - EUR | 9.073 | 8.207 | 6.410 | 4.055 | 4.316 | 10.733 | 29.648 | 2.227 | 2 | 16.651 |
| Total Expenses - EUR | 5.672 | 2.081 | 5.131 | 3.414 | 782 | 3.011 | 5.200 | 5.478 | 184 | 4.162 |
| Gross Profit/Loss - EUR | 3.401 | 6.126 | 1.278 | 641 | 3.534 | 7.723 | 24.448 | -3.252 | -182 | 12.489 |
| Net Profit/Loss - EUR | 3.129 | 5.962 | 1.150 | 576 | 3.404 | 7.401 | 23.559 | -3.318 | -182 | 10.481 |
| Employees | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medvet Prodomest Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.144 | 3.987 | 3.920 | 3.739 | 3.550 | 4.126 | 3.956 | 3.889 | 3.877 | 5.967 |
| Current Assets | 21.748 | 23.314 | 25.069 | 24.251 | 24.167 | 25.709 | 44.305 | 34.042 | 30.918 | 39.636 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 9.282 | 22.455 | 24.265 | 23.832 | 23.302 | 19.237 | 25.606 | 17.486 | 17.433 | 16.876 |
| Cash | 12.466 | 858 | 805 | 419 | 865 | 6.473 | 18.698 | 16.556 | 13.485 | 22.760 |
| Shareholders Funds | 20.965 | 26.714 | 27.412 | 27.485 | 27.397 | 29.010 | 45.931 | 36.351 | 33.221 | 43.447 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.926 | 587 | 1.577 | 505 | 320 | 826 | 2.330 | 1.580 | 1.574 | 2.156 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
8520
|
|||||||||
Comments - Medvet Prodomest Srl